Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal Therapy of
NF-kappa
B Inhibitor DHMEQ
therapies for aggressive cancer and leukemia. An
NF-kappa
B inhibitor named dehydroxymethylepoxyquinomicin
Ahmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) ,
NF-κB signalling's involvement in cancer metastasis as a key inflammation-regulatory transcription
Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) such as TAK1, MAPKs, and
NF-κB, and pro-inflammatory factor induction. Pull down assay using biotinylated
Роль мутаций в гене NF1 в спорадическом канцерогенезеThe review article presents data on somatic inactivation of
NF1 gene as a cause of sporadic